Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2000-12-19
pubmed:abstractText
The purpose of this study was to evaluate the effects of solubilizing excipients on Caco-2 transport parameters of poorly water-soluble NCEs (new chemical entities), and determine their permeability class under the BCS guidance (Biopharmaceutics Classification System). The effect of solubilizing excipients on soluble donor concentration of Sch 56592, Sch-X and Sch-Y was estimated. The transport of reference compounds and NCEs was studied across Caco-2 monolayers in absence or presence of solubilizing agents. The Caco-2 permeability of reference compounds showed good correlation with their extent of human oral absorption data. Sch 56592, Sch-X and Sch-Y exhibited high baseline Caco-2 permeability (>10(-5) cm/s). Povidone (1%) improved soluble donor concentration and flux of Sch 56592 by 40%. Other solubilizing excipients predominantly improved Sch 56592 soluble donor concentration, with either no change or a decrease in flux. With Sch-X, 1% povidone, pluronic F68, gelucir 44/14, and 3:2 propylene glycol/Tween-80 markedly improved soluble donor concentration, while increasing Sch-X flux by 40-65%. The soluble donor concentration of Sch-Y was also enhanced by excipients; however, only 1% pluronic F68 and PEG 300 increased Sch-Y flux by 35-50%. Sch 56592, Sch-X and Sch-Y are low solubility-high permeability compounds under the BCS guidance. For such poorly water-soluble NCEs, solubilizing excipients should be carefully screened based on their effects on solubility profiles and membrane transport.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alkaloids, http://linkedlifedata.com/resource/pubmed/chemical/Cimetidine, http://linkedlifedata.com/resource/pubmed/chemical/Diltiazem, http://linkedlifedata.com/resource/pubmed/chemical/Excipients, http://linkedlifedata.com/resource/pubmed/chemical/Furans, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Naphthalenes, http://linkedlifedata.com/resource/pubmed/chemical/Phenytoin, http://linkedlifedata.com/resource/pubmed/chemical/Piperidines, http://linkedlifedata.com/resource/pubmed/chemical/Poloxamer, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Povidone, http://linkedlifedata.com/resource/pubmed/chemical/Propranolol, http://linkedlifedata.com/resource/pubmed/chemical/Triazoles, http://linkedlifedata.com/resource/pubmed/chemical/gelucire 44-14, http://linkedlifedata.com/resource/pubmed/chemical/himbacine, http://linkedlifedata.com/resource/pubmed/chemical/posaconazole
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0939-6411
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
403-11
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:11072198-Alkaloids, pubmed-meshheading:11072198-Biological Transport, pubmed-meshheading:11072198-Caco-2 Cells, pubmed-meshheading:11072198-Cell Membrane Permeability, pubmed-meshheading:11072198-Cimetidine, pubmed-meshheading:11072198-Diltiazem, pubmed-meshheading:11072198-Excipients, pubmed-meshheading:11072198-Furans, pubmed-meshheading:11072198-Humans, pubmed-meshheading:11072198-Hydrogen-Ion Concentration, pubmed-meshheading:11072198-Imidazoles, pubmed-meshheading:11072198-Intestinal Absorption, pubmed-meshheading:11072198-Naphthalenes, pubmed-meshheading:11072198-Phenytoin, pubmed-meshheading:11072198-Piperidines, pubmed-meshheading:11072198-Poloxamer, pubmed-meshheading:11072198-Polyethylene Glycols, pubmed-meshheading:11072198-Povidone, pubmed-meshheading:11072198-Propranolol, pubmed-meshheading:11072198-Solubility, pubmed-meshheading:11072198-Triazoles
pubmed:year
2000
pubmed:articleTitle
Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
pubmed:affiliation
Formulation Research, Schering-Plough Research Institute, Kenilworth, NJ, USA. pratik_saha@fmc.com
pubmed:publicationType
Journal Article